CNP and heart failure: Despite recent setbacks in ongoing studies of LCZ696 in heart failure patients with overly stiff hearts (such as HFpEF; ref. 41) the results of the here-presented focused experimental studies suggest that correction or augmentation of CNP/titin signaling may moderate pathological myocardial wall stiffness and improve diastolic function at earlier or less severe disease stages.